Offstream
news

---

Changes

1. The Indonesian Food and Drug Authority grants an emergency use authorization for the Sinopharm BBIBP-CorV vaccine, where the vaccine will be used as part of a mutual vaccination scheme.
   2024-04-23 02:20:57 (First version)
2. The World Health Organization grants an emergency use authorization for the Moderna COVID-19 vaccine.
   (Current version)

---

Related

Singapore reports its first six local cases of the BA.2.75 Centaurus variant as part of the Ministry of Health’s surveillance of the COVID-19 situation in the country. However, the MOH says that the variant isn’t considered a variant of concern by the World Health Organization.
2022-07-22

The World Health Organization in an email rejects the approval Canada’s CoVLP COVID-19 vaccine over Medicago’s ties to the Philip Morris International tobacco company.
2022-03-24

The WHO issues interim recommendations for mixing and matching COVID-19 vaccine for second and booster shot, where mRNA-based vaccines can be used as subsequent doses after initial doses of the Oxford-AstraZeneca COVID-19 vaccine and vice versa, while these vaccines can be used after initial doses of Sinopharm's inactived vaccine.
2021-12-16

Vice President Kamala Harris receives a booster dose of the Moderna COVID-19 vaccine.
2021-10-30

The European Medicines Agency approves a booster dose of the Moderna COVID-19 vaccine for all adults over the age of 18, which can be administered at least six months after the second dose.
2021-10-25

Denmark suspends the use of the Moderna COVID-19 vaccine for people under the age of 18 after reports of myocarditis and meningitis, which are rare side effects of the vaccine.
2021-10-6

The Therapeutic Goods Administration grants provisional approval for the Moderna COVID-19 vaccine, becoming the fourth vaccine to be approved for use in Australia.
2021-08-9

Canada announces that it will purchase two million doses of the vaccine produced by Moderna.
2021-05-27

The World Health Organization grants emergency use approval for the single-dose Johnson & Johnson vaccine, becoming the third vaccine to be approved after the Pfizer and Moderna vaccines.
2021-03-12

The World Health Organization (WHO) recommends the use of Oxford-AstraZeneca COVID-19 vaccine by all adults worldwide, including people over age of 65 and recommends an interval of 8 to 12 weeks between the doses.
2021-02-10